First FDA approval reshapes NRx as it becomes a commercial biopharma company.
NRX Pharmaceuticals, Inc. Common Stock (NRXP) News
Latest headlines that mention NRXP, newest first · each headline opens the original publisher
- Last price
- $2.55
- Day change
- -8.93%
- Next earnings
- —
NRXP headlines
last 30 daysNRXP news alerts
Get an alert by email or push when a new headline mentions NRXP.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.